Recent advances in BMP receptor signaling

Cytokine and Growth Factor Reviews

Volumn 20, Issue 5-6, 2009, Pages 343-355

  Sieber, Christina ^a   Kopf, Jessica ^a   Hiepen, Christian ^a   Knaus, Petra ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

BMP; Cytoskeletal rearrangements; Migration; PAH; Smad

Indexed keywords

ACTIVIN RECEPTOR 1; ACTIVIN RECEPTOR LIKE KINASE 1; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CAVEOLIN; CHORDIN; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; LDN 193189; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN; NOGGIN; OSTEOGENIC PROTEIN 1; OSTEOGENIN; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; SMAD PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; BINDING AFFINITY; BONE REGENERATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL POLARITY; CELL PROLIFERATION; DROSOPHILA; ENDOCYTOSIS; GENE MUTATION; HUMAN; INHIBITION KINETICS; MECHANOTRANSDUCTION; MOLECULAR MECHANICS; NONHUMAN; OLIGOMERIZATION; ORGANOGENESIS; OSSIFYING MYOSITIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PULMONARY HYPERTENSION; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TISSUE INJURY; TRANSCRIPTION REGULATION; XENOPUS; ZEBRA FISH;

ANIMALS; BONE DISEASES; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; ENDOCYTOSIS; HUMANS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; VASCULAR DISEASES;

EID: 70649083092     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2009.10.007     Document Type: Review

References (149)

1. Spemann H., and Mangold H. Induction of embryonic primordia by implantation of organizers from a different species. 1923. Int J Dev Biol 45 (2001) 13-38
2. Sasai Y., Lu B., Piccolo S., and De Robertis E.M. Endoderm induction by the organizer-secreted factors chordin and noggin in Xenopus animal caps. Embo J 15 (1996) 4547-4555
3. Dale L., and Jones C.M. BMP signalling in early Xenopus development. Bioessays 21 (1999) 751-760
4. De Robertis E.M., and Kuroda H. Dorsal-ventral patterning and neural induction in Xenopus embryos. Annu Rev Cell Dev Biol 20 (2004) 285-308
5. Mieko Mizutani C., and Bier E. EvoD/Vo: the origins of BMP signalling in the neuroectoderm. Nat Rev Genet 9 (2008) 663-677
6. Smith W.C., and Harland R.M. Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell 70 (1992) 829-840
7. Sasai Y., Lu B., Steinbeisser H., Geissert D., Gont L.K., and De Robertis E.M. Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes. Cell 79 (1994) 779-790
8. Piccolo S., Sasai Y., Lu B., and De Robertis E.M. Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell 86 (1996) 589-598
9. Zimmerman L.B., De Jesus-Escobar J.M., and Harland R.M. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86 (1996) 599-606
10. Kuroda H., Wessely O., and De Robertis E.M. Neural induction in Xenopus: requirement for ectodermal and endomesodermal signals via Chordin, Noggin, beta-Catenin, and Cerberus. PLoS Biol 2 (2004) E92
11. Oelgeschläger M., Kuroda H., Reversade B., and De Robertis E.M. Chordin is required for the Spemann organizer transplantation phenomenon in Xenopus embryos. Dev Cell 4 (2003) 219-230
12. Schulte-Merker S., Lee K.J., McMahon A.P., and Hammerschmidt M. The zebrafish organizer requires chordino. Nature 387 (1997) 862-863
13. Bachiller D., Klingensmith J., Kemp C., Belo J.A., Anderson R.M., May S.R., et al. The organizer factors Chordin and Noggin are required for mouse forebrain development. Nature 403 (2000) 658-661
14. Collavin L., and Kirschner M.W. The secreted Frizzled-related protein Sizzled functions as a negative feedback regulator of extreme ventral mesoderm. Development 130 (2003) 805-816
15. Sieber C, Schwaerzer GK, Knaus P. Bone Morphogenetic Proteins: From Local to Systemic Therapeutics; article: BMP signaling is fine tuned on multiple levels. Vol XI. hardcover ed: Birkhäuser; 2008.
16. Little S.C., and Mullins M.C. Bone morphogenetic protein heterodimers assemble heteromeric type I receptor complexes to pattern the dorsoventral axis. Nat Cell Biol 11 (2009) 637-643
17. Canalis E., Economides A.N., and Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24 (2003) 218-235
18. Hill J.J., Qiu Y., Hewick R.M., and Wolfman N.M. Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. Mol Endocrinol 17 (2003) 1144-1154
19. Zhang H., and Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122 (1996) 2977-2986
20. Winnier G., Blessing M., Labosky P.A., and Hogan B.L. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 9 (1995) 2105-2116
21. Furuta Y., and Hogan B.L. BMP4 is essential for lens induction in the mouse embryo. Genes Dev 12 (1998) 3764-3775
22. Lawson K.A., Dunn N.R., Roelen B.A., Zeinstra L.M., Davis A.M., Wright C.V., et al. Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev 13 (1999) 424-436
23. Goldman D.C., Donley N., and Christian J.L. Genetic interaction between Bmp2 and Bmp4 reveals shared functions during multiple aspects of mouse organogenesis. Mech Dev 126 (2009) 117-127
24. Daluiski A., Engstrand T., Bahamonde M.E., Gamer L.W., Agius E., Stevenson S.L., et al. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet 27 (2001) 84-88
25. Matzuk M.M. Functional analysis of mammalian members of the transforming growth factor-beta superfamily. Trends Endocrinol Metab 6 (1995) 120-127
26. Bailon-Plaza A., Lee A.O., Veson E.C., Farnum C.E., and van der Meulen M.C. BMP-5 deficiency alters chondrocytic activity in the mouse proximal tibial growth plate. Bone 24 (1999) 211-216
27. Jena N., Martin-Seisdedos C., McCue P., and Croce C.M. BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye. Exp Cell Res 230 (1997) 28-37
28. Zhao G.Q., Liaw L., and Hogan B.L. Bone morphogenetic protein 8A plays a role in the maintenance of spermatogenesis and the integrity of the epididymis. Development 125 (1998) 1103-1112
29. Zhao G.Q., Deng K., Labosky P.A., Liaw L., and Hogan B.L. The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse. Genes Dev 10 (1996) 1657-1669
30. Yan C., Wang P., DeMayo J., DeMayo F.J., Elvin J.A., Carino C., et al. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol 15 (2001) 854-866
31. Chen H., Shi S., Acosta L., Li W., Lu J., Bao S., et al. BMP10 is essential for maintaining cardiac growth during murine cardiogenesis. Development 131 (2004) 2219-2231
32. Miyazono K., Maeda S., and Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 16 (2005) 251-263
33. Shimasaki S., Moore R.K., Otsuka F., and Erickson G.F. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 25 (2004) 72-101
34. Chen Y.G., Hata A., Lo R.S., Wotton D., Shi Y., Pavletich N., et al. Determinants of specificity in TGF-beta signal transduction. Genes Dev 12 (1998) 2144-2152
35. Knaus P., and Sebald W. Cooperativity of binding epitopes and receptor chains in the BMP/TGFbeta superfamily. Biol Chem 382 (2001) 1189-1195
36. Koenig B.B., Cook J.S., Wolsing D.H., Ting J., Tiesman J.P., Correa P.E., et al. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol 14 (1994) 5961-5974
37. Greenwald J., Groppe J., Gray P., Wiater E., Kwiatkowski W., Vale W., et al. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol Cell 11 (2003) 605-617
38. Gilboa L., Nohe A., Geissendorfer T., Sebald W., Henis Y.I., and Knaus P. Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol Biol Cell 11 (2000) 1023-1035
39. Nohe A., Hassel S., Ehrlich M., Neubauer F., Sebald W., Henis Y.I., et al. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277 (2002) 5330-5338
40. Hartung A., Bitton-Worms K., Rechtman M.M., Wenzel V., Boergermann J.H., Hassel S., et al. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol Cell Biol 26 (2006) 7791-7805
41. Gazzerro E., and Canalis E. Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7 (2006) 51-65
42. Lehmann K., Seemann P., Silan F., Goecke T.O., Irgang S., Kjaer K.W., et al. A New Subtype of Brachydactyly Type B Caused by Point Mutations in the Bone Morphogenetic Protein Antagonist NOGGIN. Am J Hum Genet 81 (2007) 388-396
43. Halbrooks P.J., Ding R., Wozney J.M., and Bain G. Role of RGM coreceptors in bone morphogenetic protein signaling. J Mol Signal 2 (2007) 4
44. Barbara N.P., Wrana J.L., and Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem 274 (1999) 584-594
45. Kirkbride K.C., Townsend T.A., Bruinsma M.W., Barnett J.V., and Blobe G.C. Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor. J Biol Chem 283 (2008) 7628-7637
46. Onichtchouk D., Chen Y.G., Dosch R., Gawantka V., Delius H., Massague J., et al. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 401 (1999) 480-485
47. Sammar M., Stricker S., Schwabe G.C., Sieber C., Hartung A., Hanke M., et al. Modulation of GDF5/BRI-b signalling through interaction with the tyrosine kinase receptor Ror2. Genes Cells 9 (2004) 1227-1238
48. Jin W., Yun C., Kim H.S., and Kim S.J. TrkC binds to the bone morphogenetic protein type II receptor to suppress bone morphogenetic protein signaling. Cancer Res 67 (2007) 9869-9877
49. Wu K.M., Huang C.J., Hwang S.P., and Chang Y.S. Molecular cloning, expression and characterization of the zebrafish bram1 gene, a BMP receptor-associated molecule. J Biomed Sci 13 (2006) 345-355
50. Yamaguchi K., Nagai S., Ninomiya-Tsuji J., Nishita M., Tamai K., Irie K., et al. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. Embo J 18 (1999) 179-187
51. Wertz J.W., and Bauer P.M. Caveolin-1 regulates BMPRII localization and signaling in vascular smooth muscle cells. Biochem Biophys Res Commun 375 (2008) 557-561
52. Satow R., Kurisaki A., Chan T.C., Hamazaki T.S., and Asashima M. Dullard promotes degradation and dephosphorylation of BMP receptors and is required for neural induction. Dev Cell 11 (2006) 763-774
53. Bengtsson L., Schwappacher R., Roth M., Boergermann J.H., Hassel S., and Knaus P. PP2A regulates BMP signalling by interacting with BMP receptor complexes and by dephosphorylating both the C-terminus and the linker region of Smad1. J Cell Sci 122 (2009) 1248-1257
54. Zakrzewicz A., Hecker M., Marsh L.M., Kwapiszewska G., Nejman B., Long L., et al. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension. Circulation 115 (2007) 2957-2968
55. Liliental J., and Chang D.D. Rack1, a receptor for activated protein kinase C, interacts with integrin beta subunit. J Biol Chem 273 (1998) 2379-2383
56. Chan M.C., Nguyen P.H., Davis B.N., Ohoka N., Hayashi H., Du K., et al. A novel regulatory mechanism of the Bone Morphogenetic Protein (BMP) signaling pathway involving the carboxyl-terminal tail domain of BMP type II receptor. Mol Cell Biol 27 (2007) 5776-5789
57. Wong W.K., Knowles J.A., and Morse J.H. Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension. Am J Respir Cell Mol Biol 33 (2005) 438-446
58. Schwappacher R., Weiske J., Heining E., Ezerski V., Marom B., Henis Y.I., et al. Novel crosstalk to BMP signalling: cGMP-dependent kinase I modulates BMP receptor and Smad activity. Embo J 28 (2009) 1537-1550
59. Foletta V.C., Lim M.A., Soosairajah J., Kelly A.P., Stanley E.G., Shannon M., et al. Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J Cell Biol 162 (2003) 1089-1098
60. Meng Q., Lux A., Holloschi A., Li J., Hughes J.M., Foerg T., et al. Identification of Tctex2beta, a novel dynein light chain family member that interacts with different transforming growth factor-beta receptors. J Biol Chem 281 (2006) 37069-37080
61. Massague J., Seoane J., and Wotton D. Smad transcription factors. Genes Dev 19 (2005) 2783-2810
62. Wrana J.L. Regulation of Smad activity. Cell 100 (2000) 189-192
63. Shi Y., and Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (2003) 685-700
64. Guo X., and Wang X.F. Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 19 (2009) 71-88
65. Shi W., Chang C., Nie S., Xie S., Wan M., and Cao X. Endofin acts as a Smad anchor for receptor activation in BMP signaling. J Cell Sci 120 (2007) 1216-1224
66. Zhang F., Qiu T., Wu X., Wan C., Shi W., Wang Y., et al. Sustained BMP signaling in osteoblasts stimulates bone formation by promoting angiogenesis and osteoblast differentiation. J Bone Miner Res 24 (2009) 1224-1233
67. Murakami G., Watabe T., Takaoka K., Miyazono K., and Imamura T. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell 14 (2003) 2809-2817
68. Inoue Y., and Imamura T. Regulation of TGF-beta family signaling by E3 ubiquitin ligases. Cancer Sci 99 (2008) 2107-2112
69. Lönn P., Moren A., Raja E., Dahl M., and Moustakas A. Regulating the stability of TGFbeta receptors and Smads. Cell Res 19 (2009) 21-35
70. Itoh S., and ten Dijke P. Negative regulation of TGF-beta receptor/Smad signal transduction. Curr Opin Cell Biol 19 (2007) 176-184
71. Goumans M.J., Valdimarsdottir G., Itoh S., Rosendahl A., Sideras P., and ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. Embo J 21 (2002) 1743-1753
72. Goumans M.J., Valdimarsdottir G., Itoh S., Lebrin F., Larsson J., Mummery C., et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 12 (2003) 817-828
73. Lebrin F., Goumans M.J., Jonker L., Carvalho R.L., Valdimarsdottir G., Thorikay M., et al. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. Embo J 23 (2004) 4018-4028
74. Daly A.C., Randall R.A., and Hill C.S. Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol Cell Biol 28 (2008) 6889-6902
75. Wrighton K.H., Lin X., Yu P.B., and Feng X.H. Transforming Growth Factor {beta} Can Stimulate Smad1 Phosphorylation Independently of Bone Morphogenic Protein Receptors. J Biol Chem 284 (2009) 9755-9763
76. Liu I.M., Schilling S.H., Knouse K.A., Choy L., Derynck R., and Wang X.F. TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch. Embo J 28 (2009) 88-98
77. Rebbapragada A., Benchabane H., Wrana J.L., Celeste A.J., and Attisano L. Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol 23 (2003) 7230-7242
78. Cassar L., Nicholls C., Pinto A.R., Li H., and Liu J.P. Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3. Faseb J 23 (2009) 1880-1892
79. Fuentealba L.C., Eivers E., Ikeda A., Hurtado C., Kuroda H., Pera E.M., et al. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 131 (2007) 980-993
80. Sapkota G., Alarcon C., Spagnoli F.M., Brivanlou A.H., and Massague J. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell 25 (2007) 441-454
81. Feng X.H., and Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 21 (2005) 659-693
82. Gould G.W., and Lippincott-Schwartz J. New roles for endosomes: from vesicular carriers to multi-purpose platforms. Nat Rev Mol Cell Biol 10 (2009) 287-292
83. Chen Y.G. Endocytic regulation of TGF-beta signaling. Cell Res 19 (2009) 58-70
84. Nohe A., Keating E., Underhill T.M., Knaus P., and Petersen N.O. Effect of the distribution and clustering of the type I A BMP receptor (ALK3) with the type II BMP receptor on the activation of signalling pathways. J Cell Sci 116 (2003) 3277-3284
85. Seet L.F., and Hong W. Endofin, an endosomal FYVE domain protein. J Biol Chem 276 (2001) 42445-42454
86. Seet L.F., and Hong W. Endofin recruits clathrin to early endosomes via TOM1. J Cell Sci 118 (2005) 575-587
87. Nohe A., Keating E., Underhill T.M., Knaus P., and Petersen N.O. Dynamics and interaction of caveolin-1 isoforms with BMP-receptors. J Cell Sci 118 (2005) 643-650
88. Gillette J.M., Larochelle A., Dunbar C.E., and Lippincott-Schwartz J. Intercellular transfer to signalling endosomes regulates an ex vivo bone marrow niche. Nat Cell Biol 11 (2009) 303-311
89. Lau K.H., Kapur S., Kesavan C., and Baylink D.J. Up-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in C57BL/6J osteoblasts as opposed to C3H/HeJ osteoblasts in part contributes to the differential anabolic response to fluid shear. J Biol Chem 281 (2006) 9576-9588
90. Mitsui F.H., Peris A.R., Cavalcanti A.N., Marchi G.M., and Pimenta L.A. Influence of thermal and mechanical load cycling on microtensile bond strengths of total and self-etching adhesive systems. Oper Dent 31 (2006) 240-247
91. Sharp L.A., Lee Y.W., and Goldstein A.S. Effect of low-frequency pulsatile flow on expression of osteoblastic genes by bone marrow stromal cells. Ann Biomed Eng 37 (2009) 445-453
92. Aspenberg P., Basic N., Tagil M., and Vukicevic S. Reduced expression of BMP-3 due to mechanical loading: a link between mechanical stimuli and tissue differentiation. Acta Orthop Scand 71 (2000) 558-562
93. Rath B., Nam J., Knobloch T.J., Lannutti J.J., and Agarwal S. Compressive forces induce osteogenic gene expression in calvarial osteoblasts. J Biomech 41 (2008) 1095-1103
94. Liedert A., Kaspar D., Blakytny R., Claes L., and Ignatius A. Signal transduction pathways involved in mechanotransduction in bone cells. Biochem Biophys Res Commun 349 (2006) 1-5
95. Robling A.G., Niziolek P.J., Baldridge L.A., Condon K.W., Allen M.R., Alam I., et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem 283 (2008) 5866-5875
96. Lin C.L., Chen T.F., Chiu M.J., Way T.D., and Lin J.K. Epigallocatechin gallate (EGCG) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3 beta activation. Neurobiol Aging 30 (2009) 81-92
97. Rangaswami H., Marathe N., Zhuang S., Chen Y., Yeh J.C., Frangos J.A., et al. Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction. J Biol Chem 284 (2009) 14796-14808
98. Jadlowiec J.A., Zhang X., Li J., Campbell P.G., and Sfeir C. Extracellular matrix-mediated signaling by dentin phosphophoryn involves activation of the Smad pathway independent of bone morphogenetic protein. J Biol Chem 281 (2006) 5341-5347
99. Schwartz Z., Simon B.J., Duran M.A., Barabino G., Chaudhri R., and Boyan B.D. Pulsed electromagnetic fields enhance BMP-2 dependent osteoblastic differentiation of human mesenchymal stem cells. J Orthop Res 26 (2008) 1250-1255
100. Lai C.F., and Cheng S.L. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells. J Biol Chem 277 (2002) 15514-15522
101. Shim J.H., Greenblatt M.B., Xie M., Schneider M.D., Zou W., Zhai B., et al. TAK1 is an essential regulator of BMP signalling in cartilage. Embo J 28 (2009) 2028-2041
102. Ma C., Liu Y., and He L. MicroRNAs - powerful repression comes from small RNAs. Sci China C Life Sci 52 (2009) 323-330
103. Qin W., Zhao B., Shi Y., Yao C., Jin L., and Jin Y. BMPRII is a direct target of miR-21. Acta Biochim Biophys Sin (Shanghai) 41 (2009) 618-623
104. Mizuno Y., Tokuzawa Y., Ninomiya Y., Yagi K., Yatsuka-Kanesaki Y., Suda T., et al. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett 583 (2009) 2263-2268
105. Rogler C.E., Levoci L., Ader T., Massimi A., Tchaikovskaya T., Norel R., et al. MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology 50 (2009) 575-584
106. Ghosh-Choudhury N., Abboud S.L., Nishimura R., Celeste A., Mahimainathan L., and Choudhury G.G. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 277 (2002) 33361-33368
107. Dupont J., McNeilly J., Vaiman A., Canepa S., Combarnous Y., and Taragnat C. Activin signaling pathways in ovine pituitary and LbetaT2 gonadotrope cells. Biol Reprod 68 (2003) 1877-1887
108. Gamell C., Osses N., Bartrons R., Ruckle T., Camps M., Rosa J.L., et al. BMP2 induction of actin cytoskeleton reorganization and cell migration requires PI3-kinase and Cdc42 activity. J Cell Sci 121 (2008) 3960-3970
109. Lee-Hoeflich S.T., Causing C.G., Podkowa M., Zhao X., Wrana J.L., and Attisano L. Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis. Embo J 23 (2004) 4792-4801
110. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., et al. Cell migration: integrating signals from front to back. Science 302 (2003) 1704-1709
111. Cunningham N.S., Paralkar V., and Reddi A.H. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci U S A 89 (1992) 11740-11744
112. Pi X., Ren R., Kelley R., Zhang C., Moser M., Bohil A.B., et al. Sequential roles for myosin-X in BMP6-dependent filopodial extension, migration, and activation of BMP receptors. J Cell Biol 179 (2007) 1569-1582
113. Bohil A.B., Robertson B.W., and Cheney R.E. Myosin-X is a molecular motor that functions in filopodia formation. Proc Natl Acad Sci U S A 103 (2006) 12411-12416
114. Liu J., Wilson S., and Reh T. BMP receptor 1b is required for axon guidance and cell survival in the developing retina. Dev Biol 256 (2003) 34-48
115. Yamauchi K., Phan K.D., and Butler S.J. BMP type I receptor complexes have distinct activities mediating cell fate and axon guidance decisions. Development 135 (2008) 1119-1128
116. Sammar M., Sieber C., and Knaus P. Biochemical and functional characterization of the Ror2/BRIb receptor complex. Biochem Biophys Res Commun 381 (2009) 1-6
117. Nishita M., Yoo S.K., Nomachi A., Kani S., Sougawa N., Ohta Y., et al. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration. J Cell Biol 175 (2006) 555-562
118. Meyer G., and Feldman E.L. Signaling mechanisms that regulate actin-based motility processes in the nervous system. J Neurochem 83 (2002) 490-503
119. Gungabissoon R.A., and Bamburg J.R. Regulation of growth cone actin dynamics by ADF/cofilin. J Histochem Cytochem 51 (2003) 411-420
120. Graupera M., Guillermet-Guibert J., Foukas L.C., Phng L.K., Cain R.J., Salpekar A., et al. Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration. Nature 453 (2008) 662-666
121. Cain R.J., and Ridley A.J. Phosphoinositide 3-kinases in cell migration. Biol Cell 101 (2009) 13-29
122. Innocenti M., Frittoli E., Ponzanelli I., Falck J.R., Brachmann S.M., Di Fiore P.P., et al. Phosphoinositide 3-kinase activates Rac by entering in a complex with Eps8, Abi1, and Sos-1. J Cell Biol 160 (2003) 17-23
123. Edlund S., Landstrom M., Heldin C.H., and Aspenstrom P. Smad7 is required for TGF-beta-induced activation of the small GTPase Cdc42. J Cell Sci 117 (2004) 1835-1847
124. Dupont S., Mamidi A., Cordenonsi M., Montagner M., Zacchigna L., Adorno M., et al. FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell 136 (2009) 123-135
125. Kardassis D., Murphy C., Fotsis T., Moustakas A., and Stournaras C. Control of transforming growth factor beta signal transduction by small GTPases. Febs J 276 (2009) 2947-2965
126. Sotobori T., Ueda T., Myoui A., Yoshioka K., Nakasaki M., Yoshikawa H., et al. Bone morphogenetic protein-2 promotes the haptotactic migration of murine osteoblastic and osteosarcoma cells by enhancing incorporation of integrin beta1 into lipid rafts. Exp Cell Res 312 (2006) 3927-3938
127. Lai T.H., Fong Y.C., Fu W.M., Yang R.S., and Tang C.H. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins. Prostate 68 (2008) 1341-1353
128. Fong Y.C., Li T.M., Wu C.M., Hsu S.F., Kao S.T., Chen R.J., et al. BMP-2 increases migration of human chondrosarcoma cells via PI3K/Akt pathway. J Cell Physiol 217 (2008) 846-855
129. Smith K.A., Chocron S., von der Hardt S., de Pater E., Soufan A., Bussmann J., et al. Rotation and asymmetric development of the zebrafish heart requires directed migration of cardiac progenitor cells. Dev Cell 14 (2008) 287-297
130. Correia A.C., Costa M., Moraes F., Bom J., Novoa A., and Mallo M. Bmp2 is required for migration but not for induction of neural crest cells in the mouse. Dev Dyn 236 (2007) 2493-2501
131. Fu M., Vohra B.P., Wind D., and Heuckeroth R.O. BMP signaling regulates murine enteric nervous system precursor migration, neurite fasciculation, and patterning via altered Ncam1 polysialic acid addition. Dev Biol 299 (2006) 137-150
132. Nie X., Luukko K., and Kettunen P. BMP signalling in craniofacial development. Int J Dev Biol 50 (2006) 511-521
133. Fiedler J., Roderer G., Gunther K.P., and Brenner R.E. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 87 (2002) 305-312
134. Lee D.H., Park B.J., Lee M.S., Lee J.W., Kim J.K., Yang H.C., et al. Chemotactic migration of human mesenchymal stem cells and MC3T3-E1 osteoblast-like cells induced by COS-7 cell line expressing rhBMP-7. Tissue Eng 12 (2006) 1577-1586
135. Mishima Y., and Lotz M. Chemotaxis of human articular chondrocytes and mesenchymal stem cells. J Orthop Res 26 (2008) 1407-1412
136. Granero-Molto F., Weis J.A., Miga M.I., Landis B., Myers T.J., O'Rear L., et al. Regenerative Effects of Transplanted Mesenchymal Stem Cells in Fracture Healing. Stem Cells 27 (2009) 1887-1898
137. David L., Mallet C., Mazerbourg S., Feige J.J., and Bailly S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109 (2007) 1953-1961
138. David L., Feige J.J., and Bailly S. Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 20 (2009) 203-212
139. Moreno-Miralles I., Schisler J.C., and Patterson C. New insights into bone morphogenetic protein signaling: focus on angiogenesis. Curr Opin Hematol 16 (2009) 195-201
140. Heinke J., Wehofsits L., Zhou Q., Zoeller C., Baar K.M., Helbing T., et al. BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis. Circ Res 103 (2008) 804-812
141. Deckers M.M., van Bezooijen R.L., van der Horst G., Hoogendam J., van Der Bent C., Papapoulos S.E., et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143 (2002) 1545-1553
142. Suzuki Y., Montagne K., Nishihara A., Watabe T., and Miyazono K. BMPs promote proliferation and migration of endothelial cells via stimulation of VEGF-A/VEGFR2 and angiopoietin-1/Tie2 signalling. J Biochem 143 (2008) 199-206
143. Hartung A., Sieber C., and Knaus P. Yin and Yang in BMP signaling: Impact on the pathology of diseases and potential for tissue regeneration. Signal Transduction 6 (2006) 314-328
144. Ferns S.J., Wehrmacher W.H., and Serratto M. Pediatric pulmonary arterial hypertension--a review. Compr Ther 35 (2009) 81-90
145. Shintani M., Yagi H., Nakayama T., Saji T., and Matsuoka R. A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. J Med Genet 46 (2009) 331-337
146. Hassel S., Eichner A., Yakymovych M., Hellman U., Knaus P., and Souchelnytskyi S. Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 4 (2004) 1346-1358
147. Shore E.M., Xu M., Feldman G.J., Fenstermacher D.A., Cho T.J., Choi I.H., et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38 (2006) 525-527
148. Yu P.B., Deng D.Y., Lai C.S., Hong C.C., Cuny G.D., Bouxsein M.L., et al. BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med 14 (2008) 1363-1369
149. Little S.C., and Mullins M.C. Extracellular modulation of BMP activity in patterning the dorsoventral axis. Birth Defects Res C Embryo Today 78 (2006) 224-242